A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Public ClinicalTrials.gov record NCT03762850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the long-term (approximately 2 years) nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with immunoglobulin A nephropathy (IgAN).
Study identification
- NCT ID
- NCT03762850
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 406 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2018 (Actual)
- Primary completion
- Aug 7, 2023 (Actual)
- Completion
- Aug 19, 2026 (Actual)
- Last update posted
- Oct 14, 2026
2018 – 2026
United States locations
- U.S. sites
- 40
- U.S. states
- 21
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Travere Investigational Site | Birmingham | Alabama | 35233 | — |
| Travere Investigational Site | Homewood | Alabama | 35209 | — |
| Travere Investigational Site | Glendale | California | 91206 | — |
| Travere Investigational Site | Montebello | California | 90640 | — |
| Travere Investigational Site | Northridge | California | 91324 | — |
| Travere Investigational Site | San Diego | California | 92103-6204 | — |
| Travere Investigational Site | San Diego | California | 92103 | — |
| Travere Investigational Site | Stanford | California | 94205 | — |
| Travere Investigational Site | Denver | Colorado | 80230 | — |
| Travere Investigational Site | Coral Springs | Florida | 33071 | — |
| Travere Investigational Site | Hollywood | Florida | 33021 | — |
| Travere Investigational Site | Miami | Florida | 33136 | — |
| Travere Investigational Site | Miami | Florida | 33186 | — |
| Travere Investigational Site | Winter Park | Florida | 32789 | — |
| Travere Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Travere Investigational Site | Nampa | Idaho | 83687 | — |
| Travere Investigational Site | Hinsdale | Illinois | 60521 | — |
| Travere Investigational Site | Muncie | Indiana | 47303 | — |
| Travere Investigational Site | Kansas City | Kansas | 66160 | — |
| Travere Investigational Site | Louisville | Kentucky | 40202 | — |
| Travere Investigational Site | Boston | Massachusetts | 02215 | — |
| Travere Investigational Site | Springfield | Massachusetts | 01104 | — |
| Travere Investigational Site | Worcester | Massachusetts | 01608 | — |
| Travere Investigational Site | Minneapolis | Minnesota | 55404 | — |
| Travere Investigational Site | Reno | Nevada | 89511 | — |
| Travere Investigational Site | Fresh Meadows | New York | 11365 | — |
| Travere Investigational Site | New York | New York | 10032 | — |
| Travere Investigational Site | Cleveland | Ohio | 44106 | — |
| Travere Investigational Site | Columbus | Ohio | 43210 | — |
| Travere Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Travere Investigational Site | Columbia | South Carolina | 29203 | — |
| Travere Investigational Site | El Paso | Texas | 79935 | — |
| Travere Investigational Site | Fort Worth | Texas | 76104 | — |
| Travere Investigational Site | Houston | Texas | 77054 | — |
| Travere Investigational Site | Lewisville | Texas | 75057 | — |
| Travere Investigational Site | San Antonio | Texas | 78207 | — |
| Travere Investigational Site | Salt Lake City | Utah | 84115 | — |
| Travere Investigational Site | Salt Lake City | Utah | 84132 | — |
| Travere Investigational Site | Tacoma | Washington | 98405 | — |
| Travere Investigational Site | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03762850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03762850 live on ClinicalTrials.gov.